Explain the diagnosis
STEMI inferior wall ACS CAG PTCA RCA occlusion VT RV dysfunction cardiology
| # | Drug | Dose | Frequency |
|---|---|---|---|
| 1 | Inj. Ceftriaxone | 1g | IV, OD (once daily) |
| 2 | Inj. Clexane (Enoxaparin) | 0.4 mL | SC, q48h (anticoagulant) |
| 3 | Tab. Deplatt-A (Aspirin + Clopidogrel) | as directed | BD (twice daily) - dual antiplatelet therapy |
| 4 | Tab. Rosuvastatin | 40 mg | OD (statin for cholesterol) |
| 5 | Tab. Ramipril | 2.5 mg | OD (ACE inhibitor for cardiac remodeling) |
| 6 | Tab. Dapa (Dapagliflozin) | 10 mg | OD (SGLT2 inhibitor - now standard post-MI care) |
| 7 | Tab. Pan (Pantoprazole) | 40 mg | OD (stomach protection) |
| 8 | Tab. Nikoran (Nicorandil) | ? mg | OD (anti-anginal) |
| 9 | Tab. (possibly Flovedm / Furosemide?) | 80 mg | OD |
| 10 | Tab. Digoxin (or Daflon?) | 0.5 mg | OD |
Note: RV infarction in the context of inferior STEMI - as noted by the ACC (2024) - occurs in ~50% of inferior STEMIs, with the culprit nearly always being proximal RCA occlusion causing RV free wall dysfunction.
Explain the diagnosis
CAD recent STEMI Killip 2 junctional bradycardia AF JSVT global hypokinesia AKI cardiology
| Parameter | Value | Interpretation |
|---|---|---|
| BP | 110/79 mmHg | Low-normal; suggests reduced cardiac output |
| PR | 72/min | Normal rate (possibly rate-controlled after arrhythmia treatment) |
| SpO2 | 96% | Slightly reduced; mild pulmonary congestion |
| I/O | 1700/800 mL | Input 1700 mL, Output 800 mL - the patient is retaining fluid (900 mL positive balance), consistent with AKI + Killip II heart failure |
State fbe diagnosis
| Condition | Status |
|---|---|
| DM (Diabetes Mellitus) | × 20 years |
| HTN (Hypertension) | × 20 years |
| Dyslipidemia | Present (+) |
| Hypo-Thyroidism | Present |
| Obesity | Present (+) |
| OSH | Present (+) - likely Obstructive Sleep Apnea/Hypopnea or OSA |
| COAD | Present (+) - Chronic Obstructive Airway Disease |
| Parameter | Value |
|---|---|
| BP | 100/60 mmHg - Hypotensive |
| PR | 28/min - Severely Bradycardic |
| SpO2 | 96-97% |
| RR | 18-20/min |
| JVP | 0 (not raised) |
| Pedal edema | 0 |
| Capillary refill | Normal |
| RBS (Random Blood Sugar) | 440 mg/dL - severely elevated |
State the diagnosis and treatment of plan
anterior STEMI thrombolysis CAG PTCA LAD occlusion LVH RWMA treatment plan cardiology
| Condition | Status |
|---|---|
| Smoker | Present (+) |
| DM | × 6 years |
| HTN | No |
| CVA (Cerebrovascular Accident) | History |
| CAD | Present |
| CKD | Present |
| HTN | (repeated, listed as "c." - chronic) |
| Parameter | Value | Interpretation |
|---|---|---|
| BP | 140/80 mmHg | Elevated |
| PR | 88/min | Normal |
| SpO2 | 96% | Mildly reduced |
| JVP | Not raised | |
| Pedal oedema | Absent | |
| Capillary refill | Normal |
| Test | Result | Significance |
|---|---|---|
| Trop I (Troponin I) | 279 (elevated) | Confirms myocardial injury/infarction |
| RFT (Renal Function Test) | Cr 40 / 1.06 / 137 / 1.05 | Creatinine slightly elevated - CKD baseline |
| Lipids | 199/197/39/122.5 | Total chol/LDL/HDL/TG - dyslipidemia |
| TSSPI | >220 | Likely Troponin/stress test value |
| NTpBNP | 728 | Elevated - indicates heart failure / LV stress |
| Albumin | 9.0 (g/L) - low | Hypoalbuminemia |
| Condition | Evidence |
|---|---|
| Concentric LVH | Echo confirmed |
| Mild LV Dysfunction | Echo: RWMA + apical akinesis |
| Elevated NTpBNP (728) | Evolving heart failure |
| CKD (background) | Creatinine elevated at baseline |
| Dyslipidemia | Lipid panel: LDL 197, HDL 39 |
| DM × 6 years | Major risk factor |
| Smoker | Ongoing risk factor |